- Home
- LAB vs ORGO Comparison
LAB vs ORGO Comparison
Compare LAB & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- ORGO
- Stock Information
- Founded
- LAB 1999
- ORGO 1985
- Country
- LAB United States
- ORGO United States
- Employees
- LAB N/A
- ORGO N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- LAB Industrials
- ORGO Health Care
- Exchange
- LAB Nasdaq
- ORGO Nasdaq
- Market Cap
- LAB 562.1M
- ORGO 665.8M
- IPO Year
- LAB 2011
- ORGO N/A
- Fundamental
- Price
- LAB $1.18
- ORGO $4.35
- Analyst Decision
- LAB Strong Buy
- ORGO Buy
- Analyst Count
- LAB 3
- ORGO 2
- Target Price
- LAB $2.88
- ORGO $5.50
- AVG Volume (30 Days)
- LAB 1.4M
- ORGO 1.2M
- Earning Date
- LAB 05-07-2025
- ORGO 05-08-2025
- Dividend Yield
- LAB N/A
- ORGO N/A
- EPS Growth
- LAB N/A
- ORGO N/A
- EPS
- LAB N/A
- ORGO N/A
- Revenue
- LAB $174,432,000.00
- ORGO $482,043,000.00
- Revenue This Year
- LAB N/A
- ORGO $3.31
- Revenue Next Year
- LAB $12.77
- ORGO $12.50
- P/E Ratio
- LAB N/A
- ORGO N/A
- Revenue Growth
- LAB 64.03
- ORGO 11.29
- 52 Week Low
- LAB $0.99
- ORGO $2.17
- 52 Week High
- LAB $3.04
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- LAB 49.14
- ORGO 45.02
- Support Level
- LAB $1.05
- ORGO $4.80
- Resistance Level
- LAB $1.21
- ORGO $5.57
- Average True Range (ATR)
- LAB 0.08
- ORGO 0.33
- MACD
- LAB 0.01
- ORGO -0.15
- Stochastic Oscillator
- LAB 61.90
- ORGO 10.62
Stock Price Comparison Chart: LAB vs ORGO
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.